CpGs Induce Differentiation of Atlantic Salmon Mononuclear Phagocytes Into Cells With Dendritic Morphology and a Proinflammatory Transcriptional Profile but an Exhausted Allostimulatory Activity by Iliev, Dimitar Borisov et al.
ORIGINAL RESEARCH
published: 13 March 2019
doi: 10.3389/fimmu.2019.00378
Frontiers in Immunology | www.frontiersin.org 1 March 2019 | Volume 10 | Article 378
Edited by:
Carolina Tafalla,
Instituto Nacional de Investigación y




Friedrich Loeffler Institut, Germany
Mark D. Fast,










Vaxxinova Norway AS, Bergen,
Norway
Specialty section:
This article was submitted to
Comparative Immunology,
a section of the journal
Frontiers in Immunology
Received: 26 November 2018
Accepted: 14 February 2019
Published: 13 March 2019
Citation:
Iliev DB, Lagos L, Thim HL,
Jørgensen SM, Krasnov A and
Jørgensen JB (2019) CpGs Induce
Differentiation of Atlantic Salmon
Mononuclear Phagocytes Into Cells
With Dendritic Morphology and a
Proinflammatory Transcriptional Profile
but an Exhausted Allostimulatory
Activity. Front. Immunol. 10:378.
doi: 10.3389/fimmu.2019.00378
CpGs Induce Differentiation of
Atlantic Salmon Mononuclear
Phagocytes Into Cells With Dendritic
Morphology and a Proinflammatory
Transcriptional Profile but an
Exhausted Allostimulatory Activity
Dimitar B. Iliev 1,2*, Leidy Lagos 1, Hanna L. Thim 1†, Sven M. Jørgensen 3, Aleksei Krasnov 3
and Jorunn B. Jørgensen 1*
1 The Norwegian College of Fishery Science, UiT The Arctic University of Norway, Tromsø, Norway, 2Department of Gene
Regulation, Institute of Molecular Biology ‘Roumen Tsanev’, Bulgarian Academy of Sciences, Sofia, Bulgaria, 3Nofima Marin
AS, Oslo, Norway
Due to their ability to present foreign antigens and prime naïve T cells, macrophages,
and dendritic cells (DCs) are referred to as professional antigen-presenting cells (APCs).
Although activated macrophages may function as APCs, these cells are particularly
effective at directly engaging pathogens through phagocytosis, and production of
antimicrobial compounds. On the other hand, DCs possess superb antigen-presenting
and costimulatory capacity and they are essential for commencement and regulation
of adaptive immune responses. In in vitro models, development of mature mammalian
DCs from monocytes requires sequential exposure to growth factors (including GM-CSF
and IL-4) and proinflammatory stimuli such as toll-like receptor (TLR) ligands. Currently,
except for IL-4/13, neither orthologs nor functional analogs of the growth factors
which are essential for the differentiation of mammalian DCs (including GM-CSF
and FLT3) have been identified in teleosts and data about differentiation of piscine
APCs is scant. In the present study, primary salmon mononuclear phagocytes (MPs)
stimulated in vitro for 5–7 days with a B-class CpG oligodeoxynucleotides (ODN
2006PS) underwent morphological differentiation and developed “dendritic” morphology,
characterized by long, branching pseudopodia. Transcriptional profiling showed that
these cells expressed high levels of proinflammatory mediators characteristic for M1
polarized MPs. However, the cells treated with CpGs for 7 days downregulated their
surfaceMHCII molecules as well as their capacity to endocytose ovalbumin and exhibited
attenuated allostimulatory activity. This concurred with transcriptional downregulation of
costimulatory CD80/86 and upregulation of inhibitory CD274 (B7-H1) genes. Despite
their exhausted allostimulatory activity, these cells were still responsive to re-stimulation
with gardiquimod (a TLR7/8 ligand) and further upregulated awide array of immune genes
including proinflammatorymediators such as intereukin-1 beta and tumor necrosis factor.
Overall, the presented data highlight the disparate effects TLR ligands may have on the
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proinflammatory status of APCs, on one side, and their antigen-presenting/costimulatory
functions, on the other. These findings also indicate that despite the poor phylogenetic
conservation of the growth factors involved in the differentiation of DCs, some of the
processes that orchestrate the development and the differentiation of professional APCs
are conserved between teleosts in mammals.
Keywords: mononuclear phagocytes, antigen-presenting cells, dendritic cells, CpG oligodeoxynucleotides,
Atlantic salmon, teleosts
INTRODUCTION
The mononuclear phagocyte (MP) system comprises circulating
monocytes, tissue resident macrophages, and monocyte-derived
DCs. The most important unifying properties of MPs are
their common myeloid origin and their potential to serve as
professional APCs. These professional APCs are innate immune
cells; however they are very important for the commencement
of the adaptive immune response (1, 2). More specifically, they
are indispensable for the activation of naïve T cells by protein
antigens and are essential for themaintenance of tolerance to self-
antigens. The MP system is phylogenetically conserved and cells
resembling mammalian monocytes, macrophages, and DCs have
been identified across different vertebrate classes (3–5).
Although macrophages are mainly engaged in direct
elimination of pathogens through endocytosis and production
of antibacterial agents, they are also capable of presenting
foreign antigens and priming naïve T cells (6). These cells have
been studied extensively in fishes and the specifics of their
development and functional diversity (including development of
M1 and M2 functional phenotypes) within teleosts have recently
been covered in review articles (7, 8).
DCs were initially “baptized” by Ralf Steinman based on
their morphology characterized by long, branching pseudopodia
(9). A unifying characteristic of DCs is their superior capability
to activate naïve T cells through presentation of MHCI and
II-associated foreign antigens and costimulatory molecules on
their surface (2, 10). Studies on mammalian DCs have been
facilitated by development of protocols for in vitro generation of
large numbers of DCs (11–14). Myeloid DCs can be generated
in vitro following incubation of monocytes with GM-CSF and
IL-4 for up to 5 days. This results in development of a
relatively homogeneous population of immature DCs which
require further activation with microbial products such as
lipopolysaccharide, bacterial DNA, and double stranded RNA or
cytokines such as TNF-α in order to achieve a mature state (15).
The maturation of DCs is hallmarked with increased expression
of MHCII and costimulatory molecules (e.g., CD80, CD86) on
their plasma membrane and decreased ability to endocytose
soluble antigens.
Piscine DC-like cells have been described in vivo in different
teleost species including salmonids, zebrafish, and medaka
(16–21); however, lack of protocols and tools for large-scale
production of mature fish DCs in vitro has hampered further
characterization of these cells. Homologs of most of the
major cytokines and growth factors involved in activation and
differentiation of various leukocyte types have been identified
and isolated in fish. However, the essential growth factors—GM-
CSF and FMS-like tyrosine kinase three ligand (FLT3L) used to
differentiate mammalian DCs in vitro (11, 22) have not been
identified in any fish species suggesting that orthologs of these
genes may be absent below the level of tetrapods.
We have previously reported that 24 h in vitro stimulation
of salmon mononuclear phagocytes with class B CpGs, a ligand
for TLR9 and TLR21 (23, 24) upregulates a number of immune
genes some of which are highly expressed in mature DCs (25).
However, data about the effects of TLR ligands on antigen-
presenting functions of piscine APCs are still scarce. In the
current study, we have investigated the effects of long-term in
vitro stimulation with TLR ligands, including CpG-B (2006PS)
and polyI:C (a TLR3/22 ligand), on primary salmon MPs. The
propensity of the CpG stimulation to induce differentiation
of MPs as shown by appearance of cells with “dendritic”
morphology prompted us to investigate the phenotypical and the
functional characteristics of these APCs. We further discuss the
capacity of the CpG stimulation to induce a proinflammatory,M1




Atlantic salmon (Salmo salar) strain Aquagen standard
(Aquagen, Kyrksæterøra, Norway) was obtained from the
Tromsø Aquaculture Research Station (Tromsø, Norway). The
fish were kept at about 10◦C in tanks supplied with running
filtered water and were fed on commercial, dry food (Skretting,
Stavanger, Norway). All experiments were approved by the
national committee for animal experimentation (Norwegian




TTTGTCGTT-3′) were purchased from Thermo Scientific and
polyI:C from InvivoGen. Cy5-conjugated CpG-B was obtained
from Eurogentech. The antibodies against the β-chain of salmon
MHCII and TLR9 have been previously described (25, 26).
The antibody against actin was purchased from Sigma Aldrich
(A2066). CellTraceTM Violet, CellTraceTM CFSE, AlexaFluor546,
and Ova-Alexa488, were purchased from Life technologies.
Frontiers in Immunology | www.frontiersin.org 2 March 2019 | Volume 10 | Article 378
Iliev et al. Effect of CpG Oligonucleotides on Salmon APCs
Isolation of Leukocytes From
Atlantic Salmon
HK and spleen leukocytes were isolated as described (27). The
density of the leukocyte suspensions was adjusted to 7 × 106
cells/ml and the cells were incubated in 6-well plates (21 ×
106 of cells/well) in L-15, supplemented with 0.1% fetal bovine
serum (FBS) for 24 h before washing. In addition to displaying
classical MP morphology, the adherent HK leukocytes were able
to phagocytose large amounts of yeast cell wall particles (data not
shown), endocytosed, and processed large amounts of ovalbumin
(27) and expressed high levels of markers for MPs including the
macrophage colony stimulator factor receptor (CSF-1R) and the
macrophage scavenger receptor MARCOmRNAs (28). Adherent
HK MPs (stimulators) and non-adherent spleen lymphocytes
(responders) were washed and incubated in L-15 supplemented
with 5% FBS, penicillin (10 U/ml), streptomycin (10 mg/ml) as
described below.
Mixed Leukocyte Reactions (MLRs)
The adherent HK MPs were either left non-stimulated or treated
with 2µM CpG-B for 24 h or 7 days and were harvested
on ice using Ca/Mg-free PBS/100mM EDTA. Stimulators and
responders were stained with CellTraceTM CFSE and CellTraceTM
Violet, respectively. Staining of stimulators with CFSE was used
to distinguish them from proliferating responders with reduced
CellTraceTM Violet staining. The cells were washed with PBS
and stained with 2µM dye at 106cells/mL density for 10min at
room temperature. After staining, the cells were washed three
times with L-15, 5% FBS using a 15min interval between each
washing. Responders were mixed with both non-stimulated and
CpG-treated stimulators from the same or other individuals in
duplicates at 2:1 ratio (1× 105/0.5× 105 cells) in 96-well round-
bottom plates and incubated for 3, 5, 7, and 14 days before flow
cytometry analysis. Fifty per cent of the medium was refreshed at
3-day intervals.
Flow Cytometry
To investigate the surface expression of MHCII together with
the Ova and CpGs uptake capacity, non-stimulated and CpG-
stimulated (2µM, 7 days) MPs were incubated with 10µg/ml of
Ova-Alexa488, or 2µM CpG-Cy5 conjugates for 1 h. The cells
were harvested on ice using Ca/Mg-free PBS/100mMEDTA. The
samples were washed with ice-cold PBS and incubated with a
polyclonal salmonMHCIIβ antibody (1,000-fold dilution) for 1 h
in PBS, 5% FBS on ice. The secondary Alexa546 goat anti-rabbit
antibody was diluted to 1µg/ml in PBS, 5% FBS and the cells were
incubated for 30min on ice prior to washing, and flow cytometry.
Samples from the MLRs (described in the previous paragraph)
were harvested and analyzed directly without staining. The cells
were analyzed using FACSAria (Becton Dickinson). Statistical
analysis was performed with Student’s t-test.
Confocal Microscopy
MPs cultured on 15mm coverslips in 24-well plates cell culture
plates (Falcon) were either left non-stimulated or treated with
2µM CpGs for 7 days. The cells were then incubated with
2µM CpG-Cy5 for 1 h, stained and analyzed as previously
described (24).
Microarray Analysis
MPs were stimulated with 2µM CpGs and 20µg/ml of polyI:C
and sampled after 24 h and 7 days. Control cells were left non-
stimulated. On day 6, Gardiquimod (1µg/ml) was added to
restimulate the cells and RNA samples were harvested from
the restimulated and the non-restimulated cells on day 7.
Cells from three individuals were stimulated in parallel. Gene
expression was analyzed using the salmonid oligonucleotide
microarray (SIQ2.0, NCBI GEO platform GPL10679) (29)
consisting of 21K features printed in duplicates on 4 × 44K
chips produced by Agilent Technologies (CA, USA). Two-
color hybridizations were applied, where test samples labeled
with Cy5 dye were competitively hybridized against control
samples labeled with Cy3 dye per array. Concentration of
total RNA was measured with NanoDrop 1,000 Spectrometer
(Thermo Scientific, Waltham, MA, USA) and quality was
assessed using Agilent 2100 Bioanalyzer with RNA Nano kits
(Agilent Technologies). Samples with RNA integrity number
(RIN) of eight or higher were accepted for microarray analyses.
RNA from cells obtained from two individuals was pooled and
used for the analysis. Unless specified otherwise, all reagents
and equipment used for microarray analyses were from Agilent
Technologies. RNA amplification and labeling were performed
using Quick Amp Labeling Kits, Two-Color, and RNA Spike-
In Kits, Two-Color following the manufacturer’s protocol for 4
× 44K microarrays; each reaction used 500 ng of total RNA.
Gene ExpressionHybridization Kit was used for fragmentation of
labeled RNA. Hybridizations to microarrays were performed in
hybridization oven (Agilent Technologies) at 65◦C and rotation
speed of 10 rpm. Arrays were washedwithGene ExpressionWash
Buffers 1 and 2 and scanned with a GenePix 4,100A (Molecular
Devices, Sunnyvale, CA, USA). GenePix software was used
for spot-grid alignment, feature extraction, and quantification.
Assessment of spot quality was done with aid of GenePix flags.
After filtration of low quality spots, Lowess normalization of
log2-expression ratios was performed. The replicates showed
close concordance of gene expression profiles (Pearson r = 0.93
± 0.01). Features with >2-fold change in both samples per
treatment were selected as differentially expressed.
Cell Surface Protein Isolation and Mass
Spectrometry Analysis
Twenty ml of HK leukocyte suspensions (7 × 106/ml) were
seeded in T75 flasks (BD Biosciences) and allowed to adhere
overnight. Following washing, adherent MPs were further
incubated without stimulation or treated with 2µM CpGs for 7
days. Cells from two individuals with confluence of 80–90% were
selected for isolation of cell surface proteins using Pierce R© Cell
Surface Protein Isolation Kit (Thermo Scientific) and following
manufacturer’s instructions. Briefly, the cells were rinsed with
ice-cold PBS and cell surface proteins were labeled with 10ml
of Sulfo-NHS-SS-Biotin solution for 30min at 4◦C. Following
a quenching reaction, the cells were collected with a scraper,
washed with TBS, lysed with 500µL of Lysis Buffer and subjected
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to low power sonication on ice. Biotinylated proteins in clarified
supernatants were captured using NeutrAvidin Agarose at RT
for 1 h. The proteins were eluted from the agarose beads using
SDS sample buffer, 50mM DTT at RT for 1 h and subjected
to SDS PAGE and Coomassie staining. Gel bands of interest
were excised and subjected to in-gel reduction, alkylation, and
tryptic digestion using 6 ng/µl trypsin (V511A, Promega).
Peptide mixtures containing 1% formic acid were loaded onto a
nanoAcquityTMUltra Performance LC (Waters), containing a 3-
µm Symmetry R© C18 Trap column (180µm × 22mm) (Waters)
in front of a 3-µm AtlantisTM C18 analytical column (100µm
× 100mm)(Waters). Peptides were separated with a gradient
of 5–90% acetonitrile, 0.1% formic acid, with a flow of 0.4
µl/min eluted to a Q-TOF Ultima Global mass spectrometer
(Micromass/Waters), and subjected to data-dependent tandem
mass spectrometry analysis. Peak lists were generated by the
ProteinLynx Global server software (version 2.1), and the
resulting pkl files were searched against the NCBInr 20090214
protein sequence database using MASCOT search engine (http://
www.matrixscience.com/). Peptide mass tolerances used in the
search were 100 ppm, and fragment mass tolerance was 0.1 Da.
Western Blot Analysis (WB)
The flow-through lysates which contain proteins that did not
bind to Neutravidin and LDS eluates, enriched in biotinylated
proteins were analyzed as previously described (25). Briefly,
samples dissolved in 4 X LDS were run on NuPAGE Novex
Bis-Tris 4–12% gels (Invitrogen) in MOPS running buffer. The
proteins were transferred to PVDF membranes, blocked (Tris-
buffered saline, 5% BSA, 0.1% Tween-20) for 1 h, and incubated
overnight with primary Abs (1: 1000 dilution for MHCII and
1:100 for the actin antibody) followed by 1 h of incubation with
the secondary HRP-conjugated antibodies (1: 10 000 dilution).
The blots were developed with SuperSignal West Pico substrate
(Pierce, Rockford, IL, USA).
RESULTS
Prolonged in vitro Stimulation With CpGs
Leads to Morphological Differentiation of
Salmon MPs and Development of Cells
With “Dendritic” Morphology
When adherent salmon head kidney (HK) MPs were stimulated
in vitro for >5 days with CpGs (2µM) many of the
cells developed relatively long, branching pseudopodia, a
morphological feature manifested by DCs (9) and, in some
cases, M1 macrophages (30) (Figure 1A). This was not observed
when cells were stimulated in parallel with polyI:C (20µg/ml).
After 7 days of treatment with CpGs, cells that had the original
macrophage-like morphology were also present. A time lapse
imaging showed that while many of the cells retained their
dendritic-like morphology, the shape of some of the CpG-
stimulated cells was dynamic as they could transition between
dendritic-like to macrophage-like and vice versa morphology
within a time span of 90min (Figure 1B).
FIGURE 1 | Salmon MPs develop dendritic morphology following prolonged
treatment with CpGs. (A) Images of non-stimulated MPs and cells stimulated
for 7 days with 2µM CpGs and 20µg/ml of polyI:C. The arrow indicates a
typical DC-like cell observed in the CpG-treated samples. (B) Dynamic
reorganization of the morphology of CpG-treated MPs. Cells were stimulated
as in panel A and images were taken at 30min intervals over a period of
90min. The arrow points at elongated DC-like cell which changes morphology
into a more rounded macrophage-like cell. The arrowhead indicates a cell
which undergoes the opposite changes. Images were taken at X200
magnification.
CpGs Upregulate Allostimulatory Activity
and Surface MHCII Expression in Salmon
MPs After a Short but Not After a
Prolonged Treatment
In order to estimate the allostimulatory capacity of non-
stimulated MPs and cells stimulated with CpGs for 24 h and 7
days we performedMLRs with spleen lymphocytes from different
individuals. The experimental conditions were chosen based
on preliminary experiments using responders from spleen, HK,
and blood (results not shown). Spleen lymphocytes depleted of
adherent cells showed the highest response and were further
used in the study. Using a CellTraceTM Violet Cell Proliferation
Kit we found that unlike autologous MPs, stimulators from
other individuals incubated with responder spleen lymphocytes
for 2 weeks induced modest spleen cell proliferation of the
total population as indicated by the increased percentage of
responders with reduced amount of dye. No significant response
was observed in MLRs incubated for 3, 5, and 7 days (data
not shown). The analysis setup of the flow cytometry data is
shown in Figure 2A—proliferating responders are located in the
lower left quadrant of the dot plots due to reduced CTV staining
while CFSE staining was used to gate out stimulators. Incubation
of splenocytes with stimulators from other individuals that
had been stimulated with CpGs for 24 h induced significant
proliferation response (p< 0.05), whereas autologous stimulators
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and MPs stimulated with CpGs for 7 days prior to MLRs
did not induce significant splenocyte proliferation (Figure 2B).
CpG-B have been previously shown to be a potent mitogen
for salmon splenocytes (31) and in the current study direct
stimulation of responders with CpGs for 2 weeks was used as a
positive control for the proliferation assay (Figure 2C). The CpG-
induced proliferation of salmon leukocytes requires relatively
high concentrations of CpGs (>0.5µM) (31). This, as well as
the fact that autologous stimulators treated with CpGs for 24 h
and MPs stimulated for 7 days prior to MLRs did not induce
significant splenocyte proliferation, indicates that the observed
MLR response was not due to carryover of residual CpGs. In all
of the experiments, the responders were cultured in vitro for the
same period (15 days).
Using flow cytometry, the surface expression of MHCII
and the level of Ova uptake were measured and compared
between CpG-stimulated and non-treated HK-derived MPs. The
representative results shown in Figure 3 demonstrate that there
was a slight increase of MHCII expression 1 day after the cells
were exposed to CpGs, while on day 7 the surface expression on
MHCII was substantially reduced. The uptake of fluorescent Ova
was reduced on day 1 and was even lower on day 7.
In contrast to Ova endocytosis, the uptake of CpG ODNs
was not affected in cells pre-treated with CpGs for 7 days. In
the experiment presented in Figure 4 cells were treated with
CpGs for 7 days and then incubated with fluorescent CpG-
Cy5 ODNs for 1 h prior to flow cytometry (Figure 4A) and
immunostaining/confocal microscopy (Figure 4B). The results
demonstrate that neither the level of uptake of CpGs ODNs
nor the ability to accumulate the ODNs within TLR9-positive
intracellular compartments was affected in the CpG-treated cells.
Transcriptional Response to Long-Term
CpG and PolyI:C Stimulation.
CpG-Pretreated Salmon MPs Retain Ability
to Upregulate Proinflammatory Genes
Upon Restimulation With Gardiquimod
The differentiation and maturation of APCs is a complex
process in which the cells undergo a thorough transcriptomic
reprogramming (32). Here, using a microarray platform we have
analyzed the transcriptional response of salmon MPs to the
long-term stimulation with CpGs and polyI:C. The latter, unlike
CpGs, did not induce similar morphological differentiation of
salmon MPs although it had a superior capacity to induce
upregulation of IFN-stimulated genes (ISGs) after 24 h of
stimulation (Figure S1). The results from the microarray analysis
demonstrated that, after 7 days of stimulation, CpGs both up-
and downregulated larger number of genes as compared to the
polyI:C treatment (Figure 5). Unlike polyI:C, the CpG treatment
upregulated proinflammatory cytokines (IL-1β, TNF2/3), genes
associated with inflammation (including SAA and MMP9)
and secreted TNF receptor superfamily (TNFRSF) members—
TNFRSF11B and TNFRSF6B (Figure 6, Figure S2).
Among genes known to be implicated in the antigen-
presenting functions of APCs, the CpG stimulation upregulated
CD83, and the inhibitory B7-H1 (PDL1, CD274) molecule while
it downregulated the expression of MHCII, CD80/86, and CCR9
homologs (Figure 6, Figure S2).
Interestingly, although, as mentioned above, after 24 h of
stimulation, polyI:C upregulated ISGs to a much higher extent
as compared to CpGs, after 7 days of stimulation, the opposite
was observed for many key ISGs such as CXCL10 (IP-10), Vig1,
Mx, SOCS1, STAT1, and RIG-I as well as type II IFN homologs
(Figure 6, Figure S2).
After 6 days of stimulation, the cells were restimulated with
Gardiquimod (a TLR7/8 ligand) in order to investigate if the
CpG- and polyI:C-treated cells retained their potential to respond
to stimulation with TLR ligands. Compared to non-pretreated
cells, Gardiquimod restimulation up- and downregulated fewer
genes in CpG and polyI:C pretreated cells (Figure 5) indicating
that the pretreatment modulated but did not completely suppress
the potential of the cells to respond to secondary stimulations
with TLR ligands. Figure 6 shows the expression of selected
groups of immune genes including cytokines and other immune
mediators, receptors, and cell markers and ISGs. Upregulation
of many of the selected genes was suppressed by the CpG and,
to a lower extent, by the polyI:C pretreatments. Some of the
genes whose upregulation was not repressed and was further
upregulated in CpG- pretreated cells included proinflammatory
cytokines (IL-1β , IL-22, and TNF2), and secreted TNF receptor
family members (TNFRSF11B and TNFRSF6B). Interestingly,
many ISGs were among the genes whose upregulation was
suppressed by the pretreatment including RIG-I, IFN-inducible
Gig1, IRF3, STAT1, as well as IFN-γ. Many of the genes listed
in Figure 6 can be assigned to more than one of the three
categories. Therefore, it should be mentioned that the expression
of immune receptors and cell markers, including CD64, CD83,
CD40, and the M-CSF receptor, is known to be regulated by IFNs
(33–36) and their gardiquimod-induced upregulation was also
suppressed in CpG-pretreated cells.
The microarray data was validated using real-time PCR
analysis in which samples from three individuals were analyzed
separately. As demonstrated in Figure S2, except for the lower
values, a commonly observed phenomenon caused by the lower
dynamic range of the microarray analysis as compared to
that of the real-time PCR, the two types of analysis produced
similar results. The sequences of the primers used in the real-time
PCR analysis are shown in Table S1.
Identification of Differentially Expressed
Cell Surface Proteins on Non-stimulated
and CpG-Treated Salmon MPs
To further define features that are characteristic for CpG-treated
MPs, expression of surface proteins upon CpG-treatment were
examined by mass spectrometry and compared to non-treated
cells. Samples acquired using the cell surface protein isolation
kit were analyzed with WB in order to estimate the efficiency of
the protein purification. Compared to the flow-through lysates
the pull-down samples are expected to be depleted of proteins
which are not directly associated with the plasmamembrane. The
results shown in Figure 7A demonstrate that compared to the
flow-through samples, the pull-down samples contained more
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FIGURE 2 | Short, but not prolonged treatment of salmon MPs with CpGs upregulates their allostimulatory activity. (A), adherent HK MPs were stained with CFSE
upon 24 h of stimulation with 2µM CpGs. Splenocytes stained with CellTrace Violet (CTV) were used as responders. The dot plots show that a significant number of
stimulators take up CTV which necessitates their staining with CFSE in order to distinguish them from proliferating responders with reduced CTV staining. The
CFSE-negative events were gated and displayed in histograms to quantify the percentage of proliferating splenocytes with reduced CTV staining. In the representative
histogram (bottom right), responders were cultured with non-stimulated (NS) MPs from another individual (filled gray area), and stimulators pretreated with CpGs for
24 h (black contour). (B), Stimulators pretreated with CpGs for 24 h but not 7 days show increased allostimulatory capacity (n = 5). Autologous stimulators did not
significantly activate splenocyte proliferation even after pretreatment with CpGs for 24 h (*p < 0.05). (C), Direct CpG stimulation of responders was included as a
positive control for cell proliferation (n = 4). In all of the experiments, the responders were cultured in vitro for 15 days.
FIGURE 3 | CpG stimulation reduces antigen uptake capacity of MPs and, after a prolonged treatment, downregulates surface MHCII expression. MPs were either left
untreated or stimulated with 2µM CpGs for 1 and 7 days, as indicated. The cells were incubated with 10µg/ml of Ova conjugated with AlexaFluor-488 for 1 h prior to
harvesting and analysis using flow cytometry. The numbers in the individual histograms show the mean fluorescence intensities of the stained samples (black contours).
The non-stained samples are represented with filled gray contours. Representative results from two experiments with cells from different individuals are shown.
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FIGURE 4 | Cells stimulated with CpGs for 7 days retain capacity to take up CpG ODNs and to translocate them into TLR9-positive endocytic compartments.
(A) MPs were either left non-stimulated (blue contour) or were treated with 2µM CpGs for 7 days (orange contour) prior to incubation with fluorescent (CpG-Cy5)
ODNs for 1 h and flow cytometry analysis. The filled gray contour represents cells incubated without fluorescent CpGs. (B) Non-stimulated cells (NS) and cells
pretreated with CpGs for 7 days were incubated with CpG-Cy5 for 1 h prior to fixation, permeabilization, and staining of intracellular TLR9. The endocytosed CpGs
were visualized in the far-red channel and are shown in green pseudocolor. The nuclei were stained with SYTOX Green (blue pseudocolor). The colocalization between
TLR9 and CpG-positive vesicles (yellow color) is indicated with arrows in the merged images.
FIGURE 5 | Microarray analysis—transcriptional response of salmon MPs to long term stimulation with polyI:C and CpGs and restimulation with gardiquimod. MPs
were left non-stimulated (NS) or stimulated with 2µM CpGs or 20µg/ml of polyI:C. After 6 days, samples were restimulated with 1µg/ml of Gardiquimod and RNA
from both non-restimulated (NRS) and restimulated samples was sampled on day 7. Pooled RNA samples of cells from two individuals were analyzed using a
salmonid oligonucleotide microarray. Features with fold change values of +2 and −2 as compared to the NS samples were considered up- and downregulated,
respectively. The histograms show the total numbers of up- and downregulated features in the different samples. The Venn diagrams show the numbers of common
and unique up- and downregulated genes among the samples.
MHCII while the actin levels were barely detectable, thereby
confirming the efficiency of the cell surface isolation procedure.
Major SDS PAGE protein bands present in samples of cell
surface proteins from non-stimulated MPs and cells treated with
CpGs for 7 days were isolated and analyzed using tandem mass
spectrometry (MS/MS). Samples from cells of two individuals
were run in parallel and consistently regulated bands were
selected for the analysis (Figure 7B). The analysis identified
CD45 in a high molecular weight band that was upregulated by
the CpG treatment. Another high molecular weight band which
appeared to be downregulated in CpG-treated samples contained
clathrin whereas CD18, an integrin involved in cell adhesion, was
identified in a major band that did not seem to be regulated by
the treatment in any of the two analyzed individuals. The HSP70
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FIGURE 6 | Microarray heat map showing the expression of selected immune genes. The numbers show the “fold change” values as compared to non-stimulated
cells. The heat map legend is shown in the lower right corner. Note, that genes of interest have been tentatively assigned to three groups; however, many of them can
be assigned to more than one group. Arrows indicate genes whose expression is at least 1.9-fold higher or lower in CpG + Gardiquimod samples as compared to
samples stimulated only with Gardiquimod.
family members GRP78 and HSP70 were identified in bands
which appeared to be slightly upregulated by the CpG treatment.
DISCUSSION
In the current study, long-term in vitro stimulation (>5 days)
with CpGs induced functional and phenotypical differentiation
of salmon MPs. Although these cells developed dendritic
morphology and an M1-like proinflammatory transcriptional
profile, they downregulated their surface MHCII expression, and
had an impaired allostimulatory capacity.
The differentiation of MPs into cells with dendritic
morphology appeared to correlate with upregulation of
proinflammatory genes since cells stimulated in parallel with
polyI:C did not exhibit similar morphological changes and
had fewer inflammatory mediators upregulated after 7 days of
stimulation. At the same time, the polyI:C-stimulated cells had
some IFN-inducible genes upregulated at levels compared to, or
even exceeding those in CpG-stimulated cells.
The term “dendritic cell” was introduced by Ralf Steinman,
reflecting the specific morphology of DCs isolated from
peripheral lymphoid organs (9). However, it should be noted that,
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FIGURE 7 | Mass spectrometry analysis of cell surface proteins of
non-stimulated and CpG-treated salmon MPs. The cells were either left
non-stimulated or were stimulated with CpGs for 7 days. Cell surface proteins
were labeled with biotin and purified as described in Materials and methods.
(A) The efficiency of the cell surface protein purification was confirmed with
WB analysis. Flow-through and pull-down samples enriched in proteins
associated with cell surface from control non-stimulated and CpG-stimulated
cells were run on SDS PAGE and protein levels of MHCII-β and actin were
detected with polyclonal antibodies. (B) Samples enriched in cell surface
proteins isolated from cells of two individuals were run in parallel on
SDS-PAGE, and stained with Coomassie. Bands of interest were excised, and
subjected to MS/MS analysis. The table below the gel image lists identified
proteins in bands whose ID numbers are indicated on the gel image.
under specific conditions, macrophages stimulated with LPS and
IFN-γ may also adopt a similar morphology (30), characterized
by long, branching pseudopodia. Therefore, considering all of the
data we have obtained in this study, it would be more pertinent
to conclude that the salmon MP cultures stimulated for 7 days
with CpGs were enriched in activated M1 macrophages rather
than DCs.
As with other types of primary cell cultures, the
starting cultures of adherent salmon leukocytes were not
homogenous and, most likely, included monocytes and
macrophages at different developmental stages. However,
the observation that the cells concertedly downregulated
MHCII expression and the Ova uptake capacity suggests
that the CpG-induced differentiation of these cells was
relatively synchronized.
Similar to mammalian DCs, the shape of the CpG-stimulated
salmon MPs was quite dynamic as the dendrites retracted and
expanded in different directions within minutes. As speculated
elsewhere, this property likely contributes to the antigen
presenting function of DCs by allowing the APCs to scan a larger
area and facilitate the capture of antigens (37). Regardless of the
morphological differentiation, in our study, the CpG treatment
downregulated the ability of the MPs to endocytose ovalbumin
as soon as 24 h and even further at 7 days poststimulation.
The fact that the capacity of the cells to take up CpGs was
not attenuated indicates that the CpG stimulation affected
only specific endocytic pathways, likely mannose receptor- or
scavenger receptor-mediated endocytosis.
Upon maturation, DCs upregulate surface MHCII but lose
their ability to take up and process soluble antigen (38, 39).
In the current work, the downregulation of the capacity of
CpG-stimulated MPs to take up ovalbumin may be considered
as an indication that these APCs underwent a similar process
of maturation. However, the transient upregulation followed
by downregulation of surface MHCII expression after 7 days
of treatment with CpGs indicated that during cultivation, the
cells developed an exhausted or tolerogenic phenotype which
was confirmed by the loss of their allostimulatory activity. It
is not likely that this was due to reduced viability or a general
loss of functionality since the cells retained ability to take
up CpGs and to accumulate them in TLR9-positive endocytic
compartments. In addition, although the cells responded to
restimulation with Gardiquimod by upregulating fewer genes as
compared to cell that had not been pretreated, they were still
able to upregulate expression of a number of proinflammatory
mediators. This indicates that the CpG-pretreated salmon MPs
are not exhausted per se but, as reported elsewhere, might
have been reprogrammed to respond differently to secondary
stimuli (37).
Obviously, the MHCII downregulation was due to
suppression of MHCII biosynthesis in CpG-stimulated MPs
since the MHCII-β protein levels were downregulated not only
on the cell surface but also in the whole lysates as demonstrated
by the WB analysis. Similarly, stimulation of mouse peritoneal
macrophages with CpGs downregulated the biosynthesis and
the surface expression of MHCII (40). However, in that study
the MHCII downregulation was observed after a relatively
short stimulation (18 h) and, unlike in the current work, the
treatment did not suppress the antigen uptake capacity of
murine macrophages.
It has been shown that human monocytes differentiated
into DCs with GM-CSF and IL-4 in the presence of TLR
ligands develop a tolerogenic phenotype (41). This was due to
downregulation of surface MHCII and upregulation of B7-H1,
a suppressor of T-cell activation and a marker for tolerogenic
DCs (42). Likewise, we found that the mRNA of B7-H1
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was upregulated in CpG-treated MPs, while the costimulatory
molecule CD80/CD86 was, on the contrary, downregulated.
Furthermore, TNFRSF6B, a secreted TNF decoy receptor which
is known for its capacity to induce tolerogenic phenotype in DCs
and macrophages (43, 44) was also upregulated in these cells.
Since in the current study, there was no concurrent treatment
with GM-CSF, we cannot claim that we have obtained tolerogenic
DCs; nevertheless, our data indicates that at least some of the
mechanisms that control the differentiation and the maturation
of professional APCs in presence of TLR ligands are conserved
between teleosts and mammals.
Gardiquimod is a TLR7/8 ligand and, in the current
study, it induced high expression of both proinflammatory
genes as well as IFNs and IFN-stimulated genes (ISGs). As
mentioned above, in cells pretreated with CpGs and polyI:C,
Gardiquimod upregulated fewer genes as compared to non-
pretreated cells. Furthermore, the level of upregulation of many
genes in the former samples was generally lower as compared
to the latter. A possible explanation for this is that the effect
of Gardiquimod was likely influenced by autocrine factors.
In this regard, it is possible that the attenuated induction
of many of the genes we have observed might be due to
modulation of IFN and cytokine receptor signaling. For example,
SOCS1, which was highly upregulated in the CpG–treated
cells inhibits the signaling initiated by type I and II IFN as
well as cytokines which signal through the common gamma
chain subunit of the interleukin (IL)-2 receptor (45). A strong
negative regulatory activity on IFNa1 and IFN-γ signaling
has also been exhibited by Atlantic salmon SOCS1 (46). It
has been found that SOCS1 expression can be upregulated
directly by CpGs through a STAT-independent mechanism,
a process which resulted in suppression of IFN-γ-, IL-6-,
and GM-CSF-induced STAT1 phosphorylation and prevented
the upregulation of MHCII in murine macrophages (47).
Furthermore, it has also been demonstrated that TLR-induced
SOCS1 expression in DC precursors leads to a blockade of DC
differentiation (48).
Another factor that might have been involved in attenuated
gene upregulation by autocrine factors is CD45. This is a
protein tyrosine phosphatase receptor which, like SOCS1, is
involved in negative regulation of cytokine and IFN receptor
signaling (49). In the current study, the protein analysis indicated
that the CD45 protein was highly expressed on the surface of
CpG-treated cells since the molecule was identified in a high
molecular weight band upregulated by the CpG stimulation. The
Gardiquimod restimulation induced expression of both type I
IFN and IFN-γ and therefore, the attenuated upregulation of
ISGs in CpG-pretreated cells might be, at least in part, due to
the inhibitory action of proteins such as SOCS1 and CD45 on
the autocrine cytokine signaling. On the other hand, the high
expression of ISGs in CpG-treated cells may be explained with
elevated expression of IFN-regulatory factors (IRFs), such as
IRF3 and IRF7 which themselves are ISGs. As we have already
shown, overexpression of transgenic salmon IRF3 and 7 in
different salmonid cell lines is able to activate ISRE-dependent
promoter elements which are essential for the induction of
ISGs (50).
In addition to CD45, the surface protein analysis identified
clathrin heavy chain in a down-regulated band and GRP78 and
HSP70 in a band that appeared to be upregulated by the CpG
treatment. Clathrin is a major protein involved in receptor-
mediated endocytosis (51) and its downregulation might be
related to the suppression of the antigen uptake capacity in
CpG-treated cells. GRP78 and HSP70 are both members of
the family of the HSP70 heat shock proteins and function
in the endoplasmic reticulum as molecular chaperones. In
addition, it has been found that these proteins are secreted
and have been implicated in suppression of the allostimulatory
capacity of APCs (52, 53). Therefore, HSP70 and GRP78
may have contributed to the reduced allostimulatory capacity
of salmon MPs stimulated with CpGs. The downregulation
of clathrin and the binding of HSP70 and GRP78 to the
surface of CpG-treated salmon MPs need to be confirmed using
specific antibodies and might be an interesting objective for
future studies.
In summary, CpGs induced in vitro differentiation of salmon
MPs into cells with dendritic morphology, an M1 transcriptional
profile but exhausted allostimulatory phenotype and functions.
These findings demonstrate that, despite the poor phylogenetic
conservation of the growth factors involved in the differentiation
of DCs, the major processes that orchestrate the effects of TLR
ligands on the development of APCs are conserved between
teleosts in mammals. These data also emphasize on the fact
that the potent immunostimulatory properties of a TLR ligand
would not necessarily translate into enhanced APC functions
and highlight the complexity of the activation of fish immune
cells by TLR ligands which may be used as potential adjuvants
in the aquaculture.
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